These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 23597304)

  • 1. New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.
    Greig NH; Reale M; Tata AM
    Recent Pat CNS Drug Discov; 2013 Aug; 8(2):123-41. PubMed ID: 23597304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic acetylcholine receptors: new potential therapeutic targets in antinociception and in cancer therapy.
    Tata AM
    Recent Pat CNS Drug Discov; 2008 Jun; 3(2):94-103. PubMed ID: 18537768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological approaches to targeting muscarinic acetylcholine receptors.
    Matera C; Tata AM
    Recent Pat CNS Drug Discov; 2014; 9(2):85-100. PubMed ID: 25413004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic receptor agonists and antagonists in the treatment of Alzheimer's disease.
    Clader JW; Wang Y
    Curr Pharm Des; 2005; 11(26):3353-61. PubMed ID: 16250841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic M(1) agonists in the treatment of Alzheimer's disease.
    Korczyn AD
    Expert Opin Investig Drugs; 2000 Oct; 9(10):2259-67. PubMed ID: 11060805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic opportunities for muscarinic receptors in the central nervous system.
    Felder CC; Bymaster FP; Ward J; DeLapp N
    J Med Chem; 2000 Nov; 43(23):4333-53. PubMed ID: 11087557
    [No Abstract]   [Full Text] [Related]  

  • 7. Muscarinic acetylcholine receptors as CNS drug targets.
    Langmead CJ; Watson J; Reavill C
    Pharmacol Ther; 2008 Feb; 117(2):232-43. PubMed ID: 18082893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the physiological relevance of muscarinic acetylcholine receptors in Alzheimer's disease.
    Koch HJ; Haas S; Jürgens T
    Curr Med Chem; 2005; 12(24):2915-21. PubMed ID: 16305479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders.
    Moran SP; Maksymetz J; Conn PJ
    Trends Pharmacol Sci; 2019 Dec; 40(12):1006-1020. PubMed ID: 31711626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function.
    Eglen RM
    Auton Autacoid Pharmacol; 2006 Jul; 26(3):219-33. PubMed ID: 16879488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel regulatory systems for acetylcholine release in rat striatum and anti-Alzheimer's disease drugs.
    Muramatsu I; Uwada J; Yoshiki H; Sada K; Lee KS; Yazawa T; Taniguchi T; Nishio M; Ishibashi T; Masuoka T
    J Neurochem; 2019 Jun; 149(5):605-623. PubMed ID: 30968952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin.
    Cassel JC; Jeltsch H; Neufang B; Lauth D; Szabo B; Jackisch R
    Brain Res; 1995 Dec; 704(2):153-66. PubMed ID: 8788910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic Effects Mediated by Muscarinic Receptors: Mechanisms and Pharmacological Approaches.
    De Angelis F; Tata AM
    Cent Nerv Syst Agents Med Chem; 2016; 16(3):218-226. PubMed ID: 26931765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy.
    Verma S; Kumar A; Tripathi T; Kumar A
    J Pharm Pharmacol; 2018 Aug; 70(8):985-993. PubMed ID: 29663387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manipulation of the cholinergic system.
    Geroldi C; Bianchetti A; Trabucchi M
    Funct Neurol; 1997; 12(3-4):187-91. PubMed ID: 9218975
    [No Abstract]   [Full Text] [Related]  

  • 16. Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease.
    Fisher A
    Neurotherapeutics; 2008 Jul; 5(3):433-42. PubMed ID: 18625455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered hippocampal muscarinic receptors in acetylcholinesterase-deficient mice.
    Volpicelli-Daley LA; Duysen EG; Lockridge O; Levey AI
    Ann Neurol; 2003 Jun; 53(6):788-96. PubMed ID: 12783426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic receptor ligands and their therapeutic potential.
    Eglen RM; Choppin A; Dillon MP; Hegde S
    Curr Opin Chem Biol; 1999 Aug; 3(4):426-32. PubMed ID: 10419852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic drugs affect cholinesterase activity and development of eye structures during early chick development.
    Angelini C; Costa M; Morescalchi F; Cimoli G; Coniglio L; Falugi C
    Eur J Histochem; 1998; 42(4):309-20. PubMed ID: 10068904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of oral chlorpyrifos exposure on cholinesterase activity and muscarinic receptor binding in neonatal and adult rat heart.
    Howard MD; Mirajkar N; Karanth S; Pope CN
    Toxicology; 2007 Sep; 238(2-3):157-65. PubMed ID: 17644233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.